Microaneurysm (MA) turnover increases with the progression of nonproliferative diabetic retinopathy (NPDR) and is correlated with presence of intraretinal microvascular abnormalities (IRMAs), ...

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical ...

Doctors in India are constantly raising alarms over the rise in cases of vision loss among those battling type 2 ...

Diabetic retinopathy is a common complication of diabetes, which manifests as a potentially severe eye disease that can lead ...

Diabetic retinopathy (DR) is an eye-related complication that can occur in people who have diabetes. It affects blood vessels in the retina - the "light-sensitive layer of tissue in the back of ...

Diabetic retinopathy (DR) is an eye-related complication that can occur in people who have diabetes. It affects blood vessels in the retina - the "light-sensitive layer of tissue in the back of ...

Early diabetic retinopathy generally does not call for any special eye treatments. Instead, you’ll be advised to use diet, exercise, or medication to improve your metabolic risk factors ...

Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

PDR (proliferative diabetic retinopathy): A person’s NPDR may progress to PDR. This type causes new blood vessel growth on a person’s retina, which can bleed into other parts of the eye.

Survival models using electronic health record data show promise in predicting progression to proliferative diabetic ...

The cross-sectional analysis of 359,126 patients with type 1 and type 2 diabetes, published online on June 13, 2024, in JAMA Ophthalmology, found the prevalence of diabetic retinopathy (DR ...